Carter Percy H. 4
4 · Blueprint Medicines Corp · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Carter Percy H.
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2024-06-03$106.43/sh−2,436$259,263→ 45,895 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.